Merrimack Pharmaceuticals
MACK
#8017
Rank
โ‚น19.17 B
Marketcap
โ‚น1,297
Share price
0.00%
Change (1 day)
5.26%
Change (1 year)

EPS for Merrimack Pharmaceuticals (MACK)

EPS in 2023 (TTM): -โ‚น9.03

According to Merrimack Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -โ‚น9.43. In 2022 the company made an earnings per share (EPS) of -โ‚น9.43 an increase over its 2021 EPS that were of -โ‚น15.43.

EPS history for Merrimack Pharmaceuticals from 2010 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น9.03-4.19%
2022-โ‚น9.43-38.89%
2021-โ‚น15.43-25%
2020-โ‚น20.57-81.54%
2019-โ‚น111.40-56.95%
2018-โ‚น258.80-108.5%
2017โ‚น3,043-390.35%
2016-โ‚น1,048-7.35%
2015-โ‚น1,13165%
2014-โ‚น685.56-39.39%
2013-โ‚น1,131-54.01%
2012-โ‚น2,459-53.71%
2011-โ‚น5,31340.37%
2010-โ‚น3,785

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น272.53-2,991.14%๐Ÿ‡ซ๐Ÿ‡ท France
-โ‚น71.98 663.64%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น29.14 209.09%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น161.96 1,618.18%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น483.32 5,027.27%๐Ÿ‡บ๐Ÿ‡ธ USA